醫思健康(02138.HK)截至12月31日止3個月整體銷售額逾11億港元 同比增長逾7%
格隆匯1月23日丨醫思健康(02138.HK)公吿,截至2023年12月31日止三個月,集團預期錄得:(i)季內整體銷售額不少於11億港元,較去年同期升幅不少於7%;(ii)季內集團所提供的醫療服務銷售額較去年同期升幅不少於6%;(iii)季內集團香港及澳門美學醫療、美容及養生服務的銷售額較去年同期升幅不少於5%;(iv)季內集團中國內地美學醫療、美容及養生服務的銷售額較去年同期升幅不少於3%;及(v)季內集團其他服務銷售額較去年同期升幅不少於37%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.